111 related articles for article (PubMed ID: 11558580)
1. Effect of modification of the carboxyl groups of the sialic acid binding lectin from bullfrog (Rana catesbeiana) oocyte on anti-tumor activity.
Iwama M; Ogawa Y; Sasaki N; Nitta K; Takayanagi Y; Ohgi K; Tsuji T; Irie M
Biol Pharm Bull; 2001 Sep; 24(9):978-81. PubMed ID: 11558580
[TBL] [Abstract][Full Text] [Related]
2. Effect of replacing the aspartic acid/glutamic acid residues of bullfrog sialic acid binding lectin with asparagine/glutamine and arginine on the inhibition of cell proliferation in murine leukemia P388 cells.
Ogawa Y; Iwama M; Ohgi K; Tsuji T; Irie M; Itagaki T; Kobayashi H; Inokuchi N
Biol Pharm Bull; 2002 Jun; 25(6):722-7. PubMed ID: 12081136
[TBL] [Abstract][Full Text] [Related]
3. Enzymatic properties of sialic acid binding lectin from Rana catesbeiana modified with a water-soluble carbodiimide in the presence of various nucleophiles.
Iwama M; Ogawa Y; Ohgi K; Tsuji T; Irie M
Biol Pharm Bull; 2001 Dec; 24(12):1366-9. PubMed ID: 11767103
[TBL] [Abstract][Full Text] [Related]
4. Discovery of antitumor effects of leczymes.
Tatsuta T; Hosono M
Glycoconj J; 2022 Apr; 39(2):157-165. PubMed ID: 35066741
[TBL] [Abstract][Full Text] [Related]
5. Synergistic anti-tumor effect of bullfrog sialic acid-binding lectin and pemetrexed in malignant mesothelioma.
Satoh T; Tatsuta T; Sugawara S; Hara A; Hosono M
Oncotarget; 2017 Jun; 8(26):42466-42477. PubMed ID: 28476017
[TBL] [Abstract][Full Text] [Related]
6. Sialic Acid-Binding Lectin from Bullfrog Eggs Exhibits an Anti-Tumor Effect Against Breast Cancer Cells Including Triple-Negative Phenotype Cells.
Tatsuta T; Sato S; Sato T; Sugawara S; Suzuki T; Hara A; Hosono M
Molecules; 2018 Oct; 23(10):. PubMed ID: 30347895
[TBL] [Abstract][Full Text] [Related]
7. Catalytic lectin (leczyme) from bullfrog (Rana catesbeiana) eggs.
Nitta K; Ozaki K; Tsukamoto Y; Hosono M; Ogawakonno Y; Kawauchi H; Takayanagi Y; Tsuiki S; Hakomori S
Int J Oncol; 1996 Jul; 9(1):19-23. PubMed ID: 21541475
[TBL] [Abstract][Full Text] [Related]
8. Sialic acid-binding lectin from bullfrog eggs inhibits human malignant mesothelioma cell growth in vitro and in vivo.
Tatsuta T; Satoh T; Sugawara S; Hara A; Hosono M
PLoS One; 2018; 13(1):e0190653. PubMed ID: 29298350
[TBL] [Abstract][Full Text] [Related]
9. [Basic Research on Bullfrog Egg-derived Sialic Acid-binding Lectin for Cancer Treatment].
Tatsuta T
Yakugaku Zasshi; 2022; 142(10):1045-1053. PubMed ID: 36184438
[TBL] [Abstract][Full Text] [Related]
10. Transcriptomic alterations in malignant pleural mesothelioma cells in response to long‑term treatment with bullfrog sialic acid‑binding lectin.
Tatsuta T; Nakasato A; Sugawara S; Hosono M
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880588
[TBL] [Abstract][Full Text] [Related]
11. Ribonuclease activity of sialic acid-binding lectin from Rana catesbeiana eggs.
Nitta K; Oyama F; Oyama R; Sekiguchi K; Kawauchi H; Takayanagi Y; Hakomori S; Titani K
Glycobiology; 1993 Feb; 3(1):37-45. PubMed ID: 8448385
[TBL] [Abstract][Full Text] [Related]
12. Large-scale preparation of a ribonuclease from Rana catesbeiana (bullfrog) oocytes and characterization of its specific cytotoxic activity against tumor cells.
Liao YD; Huang HC; Chan HJ; Kuo SJ
Protein Expr Purif; 1996 Mar; 7(2):194-202. PubMed ID: 8812861
[TBL] [Abstract][Full Text] [Related]
13. Leczyme: a new candidate drug for cancer therapy.
Tatsuta T; Sugawara S; Takahashi K; Ogawa Y; Hosono M; Nitta K
Biomed Res Int; 2014; 2014():421415. PubMed ID: 24864241
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cell proliferation by Rana catesbeiana and Rana japonica lectins belonging to the ribonuclease superfamily.
Nitta K; Ozaki K; Ishikawa M; Furusawa S; Hosono M; Kawauchi H; Sasaki K; Takayanagi Y; Tsuiki S; Hakomori S
Cancer Res; 1994 Feb; 54(4):920-7. PubMed ID: 8313382
[TBL] [Abstract][Full Text] [Related]
15. Sialyl-glycoconjugates in cholesterol-rich microdomains of P388 cells are the triggers for apoptosis induced by Rana catesbeiana oocyte ribonuclease.
Ogawa Y; Sugawara S; Tatsuta T; Hosono M; Nitta K; Fujii Y; Kobayashi H; Fujimura T; Taka H; Koide Y; Hasan I; Matsumoto R; Yasumitsu H; Kanaly RA; Kawsar SM; Ozeki Y
Glycoconj J; 2014 Feb; 31(2):171-84. PubMed ID: 24271942
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a Rana catesbeiana lectin-resistant mutant of leukemia P388 cells.
Nitta K; Ozaki K; Tsukamoto Y; Furusawa S; Ohkubo Y; Takimoto H; Murata R; Hosono M; Hikichi N; Sasaki K
Cancer Res; 1994 Feb; 54(4):928-34. PubMed ID: 8313383
[TBL] [Abstract][Full Text] [Related]
17. A pyrimidine-guanine sequence-specific ribonuclease from Rana catesbeiana (bullfrog) oocytes.
Liao YD
Nucleic Acids Res; 1992 Mar; 20(6):1371-7. PubMed ID: 1373237
[TBL] [Abstract][Full Text] [Related]
18. The Rana catesbeiana rcr gene encoding a cytotoxic ribonuclease. Tissue distribution, cloning, purification, cytotoxicity, and active residues for RNase activity.
Huang HC; Wang SC; Leu YJ; Lu SC; Liao YD
J Biol Chem; 1998 Mar; 273(11):6395-401. PubMed ID: 9497370
[TBL] [Abstract][Full Text] [Related]
19. Purification, and properties of a base non-specific acid ribonuclease from bullfrog (Rana catesbeiana).
Yagi H; Kobayashi H; Inokuchi N; Koyama T; Irie M
Biol Pharm Bull; 1995 Feb; 18(2):219-22. PubMed ID: 7742787
[TBL] [Abstract][Full Text] [Related]
20. Comparative base specificity, stability, and lectin activity of two lectins from eggs of Rana catesbeiana and R. japonica and liver ribonuclease from R. catesbeiana.
Okabe Y; Katayama N; Iwama M; Watanabe H; Ohgi K; Irie M; Nitta K; Kawauchi H; Takayanagi Y; Oyama F
J Biochem; 1991 May; 109(5):786-90. PubMed ID: 1917903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
